Pegunigalsidase alfa, a novel PEGylated enzyme replacement...

  • Main
  • 2019 / 03
  • Pegunigalsidase alfa, a novel PEGylated enzyme replacement...

Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: a 1-year Phase 1/2 clinical trial

Schiffmann, Raphael, Goker-Alpan, Ozlem, Holida, Myrl, Giraldo, Pilar, Barisoni, Laura, Colvin, Robert B., Jennette, J. Charles, Maegawa, Gustavo, Boyadjiev, Simeon A., Gonzalez, Derlis, Nicholls, Kat
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Journal of Inherited Metabolic Disease
DOI:
10.1002/jimd.12080
Date:
March, 2019
File:
PDF, 1.26 MB
2019
Conversion to is in progress
Conversion to is failed